title: Hepatitis B in HIV: available treatment options and approach to therapy.
abstract: In the past 5 years, three new drugs were approved for hepatitis B, bringing the total number of therapies to five nucleos(-t)ide analogues and two interferons. Some of these drugs are also active against HIV. As the complexity of hepatitis B treatment increases, it becomes important for practitioners to be familiar with the potency, resistance patterns, and response rates for each hepatitis B agent. In this article, the efficacy in HIV and the best regimens for coinfected patients are discussed for those needing treatment for both infections. A particular emphasis is placed on cross-resistance among hepatitis B drugs.
authors.affiliation: Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, 550 Peachtree Street NE, Seventh Floor, Medical Office Tower at Emory University Hospital Midtown, Atlanta, GA 30308, USA. mkosbor@emory.edu
authors.forename: Melissa
authors.initials: M
authors.lastname: Osborn
references.citation: N Engl J Med. 2003 Jan 9;348(2):177-8
references.pmid: 12519935
references.citation: Hepatology. 2005 Dec;42(6):1414-9
references.pmid: 16317671
references.citation: J Clin Virol. 2006 May;36(1):60-3
references.pmid: 16418013
references.citation: J Hepatol. 1997 Jul;27(1):18-24
references.pmid: 9252068
references.citation: N Engl J Med. 2007 Jun 21;356(25):2614-21
references.pmid: 17582071
references.citation: N Engl J Med. 2005 Jun 30;352(26):2682-95
references.pmid: 15987917
references.citation: Clin Infect Dis. 2006 Jan 15;42(2):262-70
references.pmid: 16355339
references.citation: HIV Med. 2008 Feb;9(2):82-8
references.pmid: 18257771
references.citation: JAMA. 2008 Aug 6;300(5):555-70
references.pmid: 18677028
references.citation: Hepatology. 2006 Mar;43(3):548-55
references.pmid: 16496322
references.citation: AIDS. 2005 Mar 24;19(6):593-601
references.pmid: 15802978
references.citation: Gastroenterology. 2006 Jun;130(7):2039-49
references.pmid: 16762627
references.citation: Hepatology. 2006 Nov;44(5):1110-6
references.pmid: 17058225
references.citation: Gastroenterology. 1995 Jan;108(1):165-71
references.pmid: 7806038
references.citation: Ann Intern Med. 1993 Aug 15;119(4):312-23
references.pmid: 8328741
references.citation: N Engl J Med. 2004 Sep 16;351(12):1206-17
references.pmid: 15371578
references.citation: N Engl J Med. 2006 Mar 9;354(10):1001-10
references.pmid: 16525137
references.citation: Hepatology. 1999 Apr;29(4):1306-10
references.pmid: 10094979
references.citation: AIDS. 2005 Nov 18;19(17):2036-8
references.pmid: 16260913
references.citation: Lancet. 2001 Sep 1;358(9283):718-23
references.pmid: 11551579
references.citation: N Engl J Med. 2003 Feb 27;348(9):808-16
references.pmid: 12606735
references.citation: AIDS. 2008 May 11;22(8):947-55
references.pmid: 18453854
references.citation: J Hepatol. 2008 May;48(5):714-20
references.pmid: 18207280
references.citation: AIDS. 2008 Jul 31;22(12):1399-410
references.pmid: 18614862
references.citation: Antimicrob Agents Chemother. 2004 Sep;48(9):3498-507
references.pmid: 15328117
references.citation: Gastroenterology. 2002 Dec;123(6):1812-22
references.pmid: 12454838
references.citation: Hepatology. 2007 Feb;45(2):307-13
references.pmid: 17256746
references.citation: J Hepatol. 2006 Feb;44(2):283-90
references.pmid: 16338024
references.citation: Hepatology. 1999 Nov;30(5):1302-6
references.pmid: 10534354
references.citation: Ann Intern Med. 1986 Sep;105(3):382-3
references.pmid: 3017169
references.citation: J Infect Dis. 2002 Dec 15;186(12):1844-7
references.pmid: 12447773
references.citation: Hepatology. 2007 Feb;45(2):507-39
references.pmid: 17256718
references.citation: J Infect Dis. 1989 Oct;160(4):577-82
references.pmid: 2571646
references.citation: AIDS. 2004 Nov 5;18(16):2163-70
references.pmid: 15577649
references.citation: Antivir Ther. 2005;10(6):727-34
references.pmid: 16218172
references.citation: Hepatology. 2001 Jun;33(6):1527-32
references.pmid: 11391543
references.citation: Ann Intern Med. 2007 Dec 4;147(11):745-54
references.pmid: 17909201
references.citation: J Infect Dis. 2004 Apr 1;189(7):1185-92
references.pmid: 15031786
references.citation: N Engl J Med. 2005 Jun 30;352(26):2673-81
references.pmid: 15987916
references.citation: J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):234-6
references.pmid: 19155771
references.citation: AIDS. 2008 Sep 12;22(14):1779-87
references.pmid: 18753861
references.citation: HIV Med. 2007 Jul;8(5):271-9
references.pmid: 17561872
references.citation: J Infect Dis. 1999 Sep;180(3):607-13
references.pmid: 10438346
references.citation: Gastroenterology. 2005 Aug;129(2):528-36
references.pmid: 16083710
references.citation: N Engl J Med. 2006 Mar 9;354(10):1011-20
references.pmid: 16525138
references.citation: Gut. 2006 Oct;55(10):1488-95
references.pmid: 16461777
references.citation: AIDS. 2003 Jan 3;17(1):F7-10
references.pmid: 12478090
references.citation: Hepatology. 2005 Nov;42(5):1208-36
references.pmid: 16250051
references.citation: AIDS. 2007 Mar 30;21(6):771-4
references.pmid: 17413702
references.citation: HIV Med. 2009 Jan;10(1):12-8
references.pmid: 18795964
references.citation: J Hepatol. 2008 May;48(5):728-35
references.pmid: 18329126
references.citation: Antivir Ther. 2008;13(5):705-13
references.pmid: 18771054
references.citation: N Engl J Med. 2007 Dec 20;357(25):2576-88
references.pmid: 18094378